EZH2 and esophageal squamous cell carcinoma: Increased H19 expression promoted the epithelial–mesenchymal transition, growth, and invasion of ESCC (esophageal squamous cell carcinoma) and NPC by inhibiting E-cadherin expression and modulating the STAT3/EZH2/β-catenin pathway [97].